Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210030860 210011551 1.54 73.5 Disease modification (D) 2017-12-09 2017-12-26 IBRUTINIB Y N 210030029 IBRUTINIB
210030861 210035020 0 66 Curative (C) 2015-06-27 2015-07-04 IBRUTINIB N N 210030055 IBRUTINIB
210030862 210035020 null null Curative (C) 2018-05-13 2018-05-14 IBRUTINIB 2 N 210030055 IBRUTINIB
210030863 210011555 1.64 null Curative (C) 2017-02-05 2017-02-19 IBRUTINIB N null 210030064 IBRUTINIB
210030864 210021402 1.74 60.3 Disease modification (D) 2018-12-01 2018-12-23 IBRUTINIB 02 N 210030067 IBRUTINIB
210030865 210011560 1.67 null Curative (C) 2017-03-08 2017-06-11 Rituximab 2 N 210030095 RITUXIMAB
210030866 210011560 1.67 54.8 Curative (C) 2017-08-30 2018-06-27 FCR Y N 210030095 FCR
210030867 210011563 1.52 61 Adjuvant (A) 2015-11-19 2015-11-19 Bendamustine+Rituximab(Sub Courses) N N 210030129 BENDAMUSTINE + RITUXIMAB
210030868 210011565 1.7 84 Curative (C) 2018-06-28 2018-09-01 Bendamustine+Rituximab(Sub Courses) N N 210030136 BENDAMUSTINE + RITUXIMAB
210030869 210011568 1.59 40.2 Curative (C) 2016-06-30 2016-11-09 Vincristine (weekly) N null 210030141 VINCRISTINE
210030870 210011574 1.71 78.2 Curative (C) 2016-09-11 2016-09-16 FLAIR Trial N N 210030148 FLAIR TRIAL
210030871 210011577 1.57 68.5 Curative (C) 2017-03-25 2017-09-25 FLAIR Trial 1 N 210030161 FLAIR TRIAL
210030872 210011581 null 80 Curative (C) 2019-04-22 2019-04-29 Vincristine (weekly) 2 N 210030163 VINCRISTINE
210030873 210011585 1.62 75 Palliative (P) null 2017-03-26 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB Y N 210030165 FCR
210030874 210031143 0.88 54.7 null 2015-04-24 2015-04-24 Bendamustine+Rituximab(Sub Courses) N N 210030174 BENDAMUSTINE + RITUXIMAB
210030875 210011586 1.63 41.8 Adjuvant (A) 2015-12-08 2015-12-10 VINCRISTINE 2 N 210030175 VINCRISTINE
210030876 210011589 1.75 88.3 null 2017-07-12 2017-07-12 FLAIR Trial N N 210030177 FLAIR TRIAL
210030877 210011590 1.78 72.9 Palliative (P) 2014-06-03 2014-09-18 BENDAMUSTINE + RITUXIMAB 02 N 210030184 BENDAMUSTINE + RITUXIMAB
210030878 210011591 0 62.9 Curative (C) 2018-07-11 2018-08-06 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 02 N 210030192 FCR
210030879 210011594 null 80 Curative (C) null 2018-09-25 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB Y N 210030204 FCR
210030880 210011597 1.65 64.3 Curative (C) 2018-04-19 2018-04-20 FCR 02 N 210030216 FCR
210030881 210011600 null null null null 2018-05-11 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210030227 FCR
210030882 210011602 1.73 98 Disease modification (D) 2018-03-12 2018-04-16 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 02 N 210030228 FCR
210030883 210011605 1.53 60.4 Curative (C) 2013-06-02 2013-12-12 Bendamustine+Rituximab (1st Course) N N 210030255 BENDAMUSTINE + RITUXIMAB
210030884 210011611 null 92 Palliative (P) 2015-05-09 2015-05-16 FLAIR Trial N N 210030275 FLAIR TRIAL
210030886 210011621 1.65 null Curative (C) 2017-10-22 2017-10-22 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210030325 FCR
210030887 210011625 1.64 null Disease modification (D) 2017-01-17 2017-01-21 FLAIR Trial 01 N 210030342 FLAIR TRIAL
210030888 210011629 1.6 80 Palliative (P) 2013-04-06 2013-07-13 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210030365 FCR
210030889 210011636 1.72 91.5 Curative (C) 2016-12-17 2017-01-22 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210030435 FCR
210030890 210011643 1.85 91 Palliative (P) 2017-01-17 2017-01-17 FLAIR Trial 01 N 210030441 FLAIR TRIAL
210030891 210011645 1.9 0 Curative (C) 2016-07-27 2016-08-27 FCR N N 210030443 FCR
210030892 210011651 null 89.6 Curative (C) null 2019-04-19 FCR Oral - Cycle 2 onwards 02 N 210030500 FCR
210030893 210011653 1.76 119.7 Palliative (P) 2013-05-07 2013-07-08 BENDAMUSTINE + RITUXIMAB N N 210030516 BENDAMUSTINE + RITUXIMAB
210030894 210011661 1.77 null Neo-adjuvant (N) 2016-01-05 2016-01-17 FCR Oral - Cycle 2 onwards N N 210030563 FCR
210030895 210011667 1.54 65 Curative (C) 2017-12-16 2017-12-16 FCR N N 210030592 FCR
210030896 210011668 1.67 86.8 Palliative (P) 2018-01-18 2018-01-22 Vincristine (weekly) 02 Y 210030604 VINCRISTINE
210030897 210011673 1.74 63.5 Disease modification (D) 2015-04-08 2015-11-18 FCR N N 210030624 FCR
210030898 210011678 1.67 60 Disease modification (D) 2016-10-14 2016-11-21 BENDAMUSTINE + RITUXIMAB N N 210030636 BENDAMUSTINE + RITUXIMAB
210030899 210011691 1.54 53.7 Disease modification (D) 2014-10-11 2014-12-09 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 2 N 210030760 FCR
210030900 210011694 1.63 79 Adjuvant (A) 2015-05-02 2017-08-04 BENDAMUSTINE + RITUXIMAB N N 210030786 BENDAMUSTINE + RITUXIMAB
210030901 210011701 1.6 53.7 Disease modification (D) 2014-12-28 2015-05-12 FCR 2 N 210030835 FCR
210030902 210011715 1.6 52 Palliative (P) 2018-11-08 2018-11-08 FCR Oral - Cycle 1 N N 210030947 FCR
210030903 210011723 1.79 83 Palliative (P) 2017-03-18 2017-03-28 FLAIR Trial 01 N 210031008 FLAIR TRIAL
210030904 210011728 null 79 null 2017-01-14 2017-01-14 FLAIR Trial N null 210031011 FLAIR TRIAL
210030905 210011730 1.8 91.5 Curative (C) 2014-10-23 2016-02-06 Bendamustine+Rituximab (1st Course) N N 210031025 BENDAMUSTINE + RITUXIMAB
210030906 210011751 1.54 68 Palliative (P) 2013-06-27 2013-08-29 Bendamustine+Rituximab(Sub Courses) 02 N 210031101 BENDAMUSTINE + RITUXIMAB
210030907 210011752 1.83 86.7 Palliative (P) 2018-12-28 2019-03-01 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 2 N 210031103 FCR
210030909 210011775 null 86 Palliative (P) null 2014-10-03 BENDAMUSTINE + RITUXIMAB 02 null 210031207 BENDAMUSTINE + RITUXIMAB
210030910 210011778 null 69.8 Not known (9) null 2017-10-28 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 02 N 210031224 FCR
210030911 210031178 1.29 null Adjuvant (A) 2013-05-22 2013-06-07 Bendamustine+Rituximab(Sub Courses) N null 210031265 BENDAMUSTINE + RITUXIMAB